A Phase I Study Using Most Closely HLA-matched BK Virus-specific T Lymphocytes for the Treatment of BK Virus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-B)

Trial Profile

A Phase I Study Using Most Closely HLA-matched BK Virus-specific T Lymphocytes for the Treatment of BK Virus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-B)

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 10 Nov 2016

At a glance

  • Drugs Polyomavirus specific T cells ViraCyte (Primary)
  • Indications Human polyomavirus infections
  • Focus Adverse reactions
  • Sponsors ViraCyte
  • Most Recent Events

    • 31 Oct 2016 Planned initiation date changed from 1 Mar 2016 to 1 Jan 2017.
    • 05 Feb 2016 Planned initiation date changed from 1 Jan 2016 to 1 Mar 2016, as reported by ClinicalTrials.gov.
    • 10 Dec 2015 Planned initiation date changed from 1 Oct 2015 to 1 Jan 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top